D
David James Ballance
Researcher at Human Genome Sciences
Publications - 24
Citations - 1204
David James Ballance is an academic researcher from Human Genome Sciences. The author has contributed to research in topics: Fusion protein & Nucleic acid. The author has an hindex of 5, co-authored 24 publications receiving 1204 citations.
Papers
More filters
Patent
Albumin Fusion Proteins
TL;DR: The present invention encompasses albumin fusion proteins as discussed by the authors, as well as vectors containing these nucleic acids, host cells transformed with the nucleic acid vectors, and methods of making the fusion proteins of the invention.
Patent
Albumin fusion proteins comprising GLP-1 polypeptides
TL;DR: The present invention encompasses albumin fusion proteins as mentioned in this paper, as well as vectors containing these nucleic acids, host cells transformed with the nucleic acid vectors, and methods of making the fusion proteins of the invention.
Patent
Dipeptidyl-peptidase protected proteins
TL;DR: In this article, modified therapeutic polypeptides or peptides are partially or completely protected from DPP activity by adding at least one additional amino acid at the amino terminus.
Patent
Natriuretic peptide modified transferrin fusion proteins
TL;DR: Fusion proteins of transferrin and natriuretic peptides with increased serum half-life or serum stability are disclosed in this paper, which includes those modified so that the transferrin moiety exhibits no or reduced glycosylation, binding to iron and/or binding to the receptor.
Patent
Peptide yy modified transferrin fusion proteins
TL;DR: In this article, modified fusion proteins of transferring and therapeutic proteins or peptides including, with increased serum half-life or serum stability are disclosed, and preferred fusion proteins include those modified so that the transferrin moiety exhibits no or reduced glycosylation, binding to iron and/or binding to the receptor.